Learn More
Epidermal growth factor receptor (EGFR) inhibitors have demonstrated efficacy in squamous cell carcinoma of the head and neck (SCCHN). In addition to EGFR, other ErbB family members are expressed and activated in SCCHN. Afatinib is an ErbB family blocker that has been approved for treating patients with EGFR-mutated nonsmall cell lung cancer. We sought to(More)
OBJECTIVE To determine the incidence and type of complications, as well as patient satisfaction, associated with the Baha system. STUDY DESIGN Retrospective case review. SETTING The Silverstein Institute, Sarasota, Florida, and the Columbia University Medical Center, New York, New York. PATIENTS Patients with conductive/mixed hearing loss and(More)
  • 1